Latest News about Dea
Recent news which mentions Dea
DEA And Cannabis Rescheduling: A Rollercoaster Ride You Don't Want To Miss, But Keep Your Seatbelts On
May 07, 2024
From Benzinga
Post Cannabis Rescheduling: What's Next For Marijuana Giants? Potential $1.1B Cash Flow Boost From IRS 280E Removal
May 07, 2024
From Benzinga
Criminal Defense Lawyers To Biden: Release Pot Prisoners As DEA Moves To Reclassify Cannabis
May 06, 2024
From Benzinga
GOP Senator Bashes Dems' Push For Marijuana Legalization As Pro-Criminal & Anti-American: 'It's Obscene'
May 04, 2024
From Benzinga
Billions On The Move: Tracking Market Cap Changes In Top Cannabis Firms After DEA Rescheduling Announcement
May 01, 2024
From Benzinga
DEA Moves To Reschedule Weed, Cannabis Stocks Go For Wild Ride, Pummel Short Sellers With $210M In Losses
May 01, 2024
From Benzinga
From Benzinga
Cannabis Stocks React To DEA Rescheduling: Canopy & Aurora Surge, Tilray, WM Tech Hold Steady
April 30, 2024
From Benzinga
Rep Blumenauer On Marijuana Reclassification: 'Legalization Is Inevitable, Biden-Harris Admin Is Listening' To The People
April 30, 2024
From Benzinga
DEA's Move To Reclassify Cannabis Seen As 'Significant,' But Fails To Resolve State-Federal Conflict
April 30, 2024
Tickers
DEA
From Benzinga
From Benzinga
US Cannabis Council Call DEA Historic Decision To Reclassify Cannabis 'A Tectonic Shift'
April 30, 2024
Tickers
DEA
From Benzinga
Breaking: DEA Reportedly Moves To Reschedule Cannabis, Stocks Rise Sharply On The News
April 30, 2024
From Benzinga
Tickers
DEA
From InvestorPlace
Senators Warren, Fetterman Plus 18 More Dems Tell DEA 'It's Time To Act' On Cannabis Rescheduling
April 25, 2024
From Benzinga
DEA Sanctions Religious Use Of Ayahuasca But Refuses Psilocybin For Cancer Patients' Pain Relief
April 24, 2024
From Benzinga
DEA Public Comment Period And A Cannabis-Related Crypto Bill? You Heard It First At Benzinga Conference
April 19, 2024
From Benzinga
Analyst Reacts To FDA Commish Comments: Medical And Recreational Cannabis Could Have Separate Regulations
April 12, 2024
From Benzinga
FDA Commissioner To House Committee: 'There's No Reason For DEA To Delay' Cannabis Rescheduling
April 12, 2024
From Benzinga
Why Real Estate Stocks Were Hurting Today
April 10, 2024
From Motley Fool
'This Is Insanity, Someone's Got To Act,' Marijuana Researcher Files Fed Lawsuit Against DEA Over 'Unconstitutional Process'
April 10, 2024
From Benzinga
These Top REITs Have Yields Up to 9.1%
April 09, 2024
From Benzinga
EXCLUSIVE: DEA-Licensed Cannabis Co. Maridose To Launch Series A Funding Round At Upcoming Benzinga Conference
April 05, 2024
From Benzinga
DEA Revisits Proposed Ban On Two Psychedelic Compounds: Researchers Disagree, Insist On Hearings
April 02, 2024
From Benzinga
From Benzinga
DEA Comes Out Of The Shadows To Ensure Cannabis Rescheduling Process Is Not Being Done Under 'Shroud Of Secrecy'
March 28, 2024
From Benzinga
GOP Mitt Romney Pens Letter To DEA Bashing Cannabis Rescheduling, Dems' Letter To DOJ Bashes Broken Promises
March 27, 2024
From Benzinga
Rep. Blumenauer Grills Fed Health Agency For Clarity On Cannabis Rescheduling As Debate Heats Up
March 21, 2024
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.